Literature DB >> 12650595

The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi.

Andrzej Myc1, Thomas Vanhecke, Jeffrey J Landers, Tarek Hamouda, James R Baker.   

Abstract

Surfactant nanoemulsions are water in oil preparations that proved to have a broad spectrum biocidal activity against a variety of microorganisms including Gram-positive and Gram-negative bacteria, spores and enveloped viruses. These preparations are non-toxic to the skin, mucous membrane and gastrointestinal tissues at biocidal concentrations. In this study, 0.1% of the nanoemulsion designated X8W60PC has shown fungicidal activity against yeast including Candida albicans and C. tropicalis in 15 minutes. C. tropicalis was more sensitive than C. albicans, which required a longer time or a higher concentration of the nanoemulsion to achieve killing. Neutral to slightly alkaline pH was more effective in killing the yeast cells than acidic pH. Using the minimum inhibitory concentration assay, 0.08% of the nanoemulsion was inhibitory to C. albicans, and parapsilosis and filamentous fungi including Microsporum gypseum, Trichophyton mentagrophytes, Trichophyton rubrum, Aspergillus fumigatus and Fusarium oxysporum. None of the individual ingredients was as effective a fungicidal as the nanoemulsion at equivalent concentration. This shows that the nanoemulsion structure is an important factor in the anti-fungal activity. The X8W60PC has great potential as a topical anti-fungal agent and further investigation into the mechanism of fungicidal action is warranted.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12650595     DOI: 10.1023/a:1021129710316

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  20 in total

1.  A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi.

Authors:  T Hamouda; A Myc; B Donovan; A Y Shih; J D Reuter; J R Baker
Journal:  Microbiol Res       Date:  2001       Impact factor: 5.415

2.  Comparison of clotrimazole cream, Whitfield's ointment and Nystatin ointment for the topical treatment of ringworm infections, pityriasis versicolor, erythrasma and candidiasis.

Authors:  Y M Clayton; B L Connor
Journal:  Br J Dermatol       Date:  1973-09       Impact factor: 9.302

3.  Evolution of drug resistance in experimental populations of Candida albicans.

Authors:  L E Cowen; D Sanglard; D Calabrese; C Sirjusingh; J B Anderson; L M Kohn
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

4.  Prevention of murine influenza A virus pneumonitis by surfactant nano-emulsions.

Authors:  B W Donovan; J D Reuter; Z Cao; A Myc; K J Johnson; J R Baker
Journal:  Antivir Chem Chemother       Date:  2000-01

Review 5.  Uses of inorganic hypochlorite (bleach) in health-care facilities.

Authors:  W A Rutala; D J Weber
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

Review 6.  Factors in the emergence of infectious diseases.

Authors:  S S Morse
Journal:  Emerg Infect Dis       Date:  1995 Jan-Mar       Impact factor: 6.883

7.  Topical antimicrobial toxicity.

Authors:  W Lineaweaver; R Howard; D Soucy; S McMorris; J Freeman; C Crain; J Robertson; T Rumley
Journal:  Arch Surg       Date:  1985-03

8.  Comparison of hexamethyldisilazane (HMDS), Peldri II, and critical-point drying methods for scanning electron microscopy of biological specimens.

Authors:  D F Bray; J Bagu; P Koegler
Journal:  Microsc Res Tech       Date:  1993-12-15       Impact factor: 2.769

Review 9.  The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens.

Authors:  F C Tenover; J M Hughes
Journal:  JAMA       Date:  1996 Jan 24-31       Impact factor: 56.272

10.  Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.

Authors:  W Krüger; M Stockschläder; B Rüssmann; C Berger; M Hoffknecht; I Sobottka; B Kohlschütter; G Kroschke; N Kröger; M Horstmann
Journal:  Br J Haematol       Date:  1995-11       Impact factor: 6.998

View more
  14 in total

1.  Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine.

Authors:  P E Makidon; J Knowlton; J V Groom; L P Blanco; J J LiPuma; A U Bielinska; J R Baker
Journal:  Med Microbiol Immunol       Date:  2009-12-06       Impact factor: 3.402

2.  In vitro antibacterial activity of NB-003 against Propionibacterium acnes.

Authors:  J Pannu; A McCarthy; A Martin; T Hamouda; S Ciotti; L Ma; J Sutcliffe; J R Baker
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

3.  Nanoemulsion nasal adjuvant W₈₀5EC induces dendritic cell engulfment of antigen-primed epithelial cells.

Authors:  Andrzej Myc; Jolanta F Kukowska-Latallo; Douglas M Smith; Crystal Passmore; Tiffany Pham; Pamela Wong; Anna U Bielinska; James R Baker
Journal:  Vaccine       Date:  2012-12-25       Impact factor: 3.641

4.  Antimicrobial activity of nanoemulsion on cariogenic planktonic and biofilm organisms.

Authors:  Karthikeyan Ramalingam; Bennett T Amaechi; Rawls H Ralph; Valerie A Lee
Journal:  Arch Oral Biol       Date:  2011-07-31       Impact factor: 2.633

5.  Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury.

Authors:  Mark R Hemmila; Aladdein Mattar; Michael A Taddonio; Saman Arbabi; Tarek Hamouda; Peter A Ward; Stewart C Wang; James R Baker
Journal:  Surgery       Date:  2010-03-02       Impact factor: 3.982

6.  Antimicrobial activity of nanoemulsion on cariogenic Streptococcus mutans.

Authors:  Ramalingam Karthikeyan; Bennett T Amaechi; H Ralph Rawls; Valerie A Lee
Journal:  Arch Oral Biol       Date:  2010-11-26       Impact factor: 2.633

7.  Anti-cariogenic effect of a cetylpyridinium chloride-containing nanoemulsion.

Authors:  Valerie A Lee; Ramalingam Karthikeyan; H Ralph Rawls; Bennett T Amaechi
Journal:  J Dent       Date:  2010-06-17       Impact factor: 4.379

8.  In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.

Authors:  John J LiPuma; Sivaprakash Rathinavelu; Bridget K Foster; Jordan C Keoleian; Paul E Makidon; Linda M Kalikin; James R Baker
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

9.  NB-002, a novel nanoemulsion with broad antifungal activity against dermatophytes, other filamentous fungi, and Candida albicans.

Authors:  J Pannu; A McCarthy; A Martin; T Hamouda; S Ciotti; A Fothergill; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2009-05-11       Impact factor: 5.191

10.  Antimicrobial activity of nanoemulsion in combination with cetylpyridinium chloride in multidrug-resistant Acinetobacter baumannii.

Authors:  Yoon Y Hwang; Karthikeyan Ramalingam; Diane R Bienek; Valerie Lee; Tao You; Rene Alvarez
Journal:  Antimicrob Agents Chemother       Date:  2013-05-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.